KK
KLP Kapitalforvaltning Portfolio holdings
AUM
$23.2B
This Quarter Return
+4.67%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$21.1B
AUM Growth
–
Cap. Flow
+$21.1B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
31.62%
Holding
2,288
New
2,288
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Apple
AAPL
|
$1.45B |
| 2 |
NVIDIA
NVDA
|
$1.23B |
| 3 |
Microsoft
MSFT
|
$1.12B |
| 4 |
Amazon
AMZN
|
$698M |
| 5 |
Meta Platforms (Facebook)
META
|
$447M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 32.86% |
| 2 | Financials | 13.45% |
| 3 | Consumer Discretionary | 11.11% |
| 4 | Healthcare | 10.73% |
| 5 | Communication Services | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBL
2226
CBL Properties
CBL
$985M
| $55.9K | ﹤0.01% | +1,900 | New | +$55.9K |
|
2227
Custom Truck One Source
CTOS
$1.39B
| $55.8K | ﹤0.01% | +11,600 | New | +$55.8K |
|
2228
Haverty Furniture Companies
HVT
$367M
| $55.7K | ﹤0.01% | +2,500 | New | +$55.7K |
|
2229
Anterix
ATEX
$445M
| $55.2K | ﹤0.01% | +1,800 | New | +$55.2K |
|
2230
Titan International
TWI
$564M
| $54.3K | ﹤0.01% | +8,000 | New | +$54.3K |
|
2231
Definitive Healthcare
DH
$419M
| $54.3K | ﹤0.01% | +13,200 | New | +$54.3K |
|
2232
Regenxbio
RGNX
$451M
| $54.1K | ﹤0.01% | +7,000 | New | +$54.1K |
|
2233
Clear Channel Outdoor Holdings
CCO
$616M
| $53.4K | ﹤0.01% | +39,000 | New | +$53.4K |
|
|
AMPS
2234
DELISTED
Altus Power, Inc.
AMPS
| $53.3K | ﹤0.01% | +13,100 | New | +$53.3K |
|
2235
Korro Bio
KRRO
$217M
| $53.3K | ﹤0.01% | +1,400 | New | +$53.3K |
|
2236
Atlanta Braves Holdings Series A
BATRA
$2.98B
| $53K | ﹤0.01% | +1,300 | New | +$53K |
|
2237
Frontier Group Holdings
ULCC
$1.12B
| $50.5K | ﹤0.01% | +7,100 | New | +$50.5K |
|
2238
Oric Pharmaceuticals
ORIC
$994M
| $50K | ﹤0.01% | +6,200 | New | +$50K |
|
2239
National Research Corp
NRC
$339M
| $49.7K | ﹤0.01% | +2,800 | New | +$49.7K |
|
2240
Corsair Gaming
CRSR
$947M
| $49.6K | ﹤0.01% | +7,500 | New | +$49.6K |
|
2241
Legacy Housing
LEGH
$667M
| $49.4K | ﹤0.01% | +2,000 | New | +$49.4K |
|
|
SAGE
2242
DELISTED
Sage Therapeutics
SAGE
| $48.9K | ﹤0.01% | +9,000 | New | +$48.9K |
|
2243
OmniAb
OABI
$230M
| $48.6K | ﹤0.01% | +13,720 | New | +$48.6K |
|
2244
4D Molecular Therapeutics
FDMT
$288M
| $47.9K | ﹤0.01% | +8,600 | New | +$47.9K |
|
2245
Advantage Solutions
ADV
$593M
| $47.9K | ﹤0.01% | +16,400 | New | +$47.9K |
|
2246
Movado Group
MOV
$404M
| $47.2K | ﹤0.01% | +2,400 | New | +$47.2K |
|
2247
Westrock Coffee
WEST
$512M
| $46.9K | ﹤0.01% | +7,300 | New | +$46.9K |
|
2248
Tourmaline Bio
TRML
$601M
| $46.6K | ﹤0.01% | +2,300 | New | +$46.6K |
|
2249
Y-mAbs Therapeutics
YMAB
$388M
| $46.2K | ﹤0.01% | +5,900 | New | +$46.2K |
|
|
LENZ
2250
LENZ Therapeutics
LENZ
$1.1B
| $46.2K | ﹤0.01% | +1,600 | New | +$46.2K |
|